22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Update

22nd Century Group, Inc. (NASDAQ:XXII) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 91,500 shares, a growth of 1,933.3% from the December 31st total of 4,500 shares. Currently, 19.5% of the shares of the company are short sold. Based on an average daily volume of 109,400 shares, the days-to-cover ratio is presently 0.8 days.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on XXII. StockNews.com downgraded 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st. Weiss Ratings reissued a “sell (e+)” rating on shares of 22nd Century Group in a report on Saturday, January 18th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP bought a new position in shares of 22nd Century Group, Inc. (NASDAQ:XXII) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is currently owned by hedge funds and other institutional investors.

22nd Century Group Stock Performance

XXII stock opened at $4.63 on Wednesday. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. The company’s 50-day moving average price is $7.92 and its 200 day moving average price is $34.13. 22nd Century Group has a 52 week low of $3.90 and a 52 week high of $581.85.

22nd Century Group (NASDAQ:XXII) last released its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. The company had revenue of $5.95 million during the quarter.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.